Mixing randomisation

Now suppose that the mean survival times are observed to be 21.5 months in A and 27.8 months in group B. What conclusions can we draw It is very difficult the difference we have seen could be due to treatment differences or could be caused by the imbalance in terms of differential risk across the groups, or a mixture of the two. Statisticians talk in terms of confounding (just a fancy way of saying mixed up ) between the treatment effect and the effect of baseline risk. This situation is very difficult to unravel and we avoid it by stratified randomisation to ensure that the case mix in the treatment groups is comparable. 

Dynamic allocation moves away from having a pre-specified randomisation list and the allocation of patients evolves as the trial proceeds. The method looks at the current balance, in terms of the mix of patients and a number of pre-specified factors, and allocates the next patient in an optimum way to help redress any imbalances that exist at that time. 

Option 3 this is the only valid option. It is the only option that compares groups which are alike in terms of the mix of patients. This is the intention-to-treat option which compares the groups as randomised. 

Fig. 6. Significance testing principle. The probability is estimated for a randomly formed similarity value to be of higher or equal the true similarity between Set 1 and Set 2. A randomised version of Set 2 denoted Set 2, is formed by mixing the Ids (names) for the rows in the data table of Set 2.

Takahashi et al. [1965TAKAVES2] and Westmm et al. [1965WES/TAK2] have measured the low-temperature heat capacities of two samples of the dicarbide, with compositions of ThCi 9s(cr) and ThCi 93(01) respectively. The former sample probably contained some free carbon, but the consistent values of ((298.15 K) - S (() K)) of (68.6 + 0.3) J K mol from the two studies has been taken to refer to the ThCi.94(cr) composition. The assumption that this phase contains randomly mixed C and C2 groups then gives a randomisation entropy of (ThQ 94, cr, 0 K) = (1.9 + 0.3) J-K -mol, to give ... 

Figure 5.73. The z-filter seheme for suppressing zero-quantum contributions in ID TOCSY. The delay is randomly varied between experiments and the resulting spectra co-added. When using DIPSI-2, the two S periods on either side of the isotropic mixing scheme can act directly as independent periods and may be randomised in a similar manner.

Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ. RADIANCE 2 Investigators. Torcetrapib and carotid intima-media thickness in mixed dyslipidae-mia (RADIANCE 2 study) a randomised, double-blind trial. Lancet 2007 370(9582) 153-60. 

A review of 20 clinical trials published between 1979 and 2012 showed that subjects randomised to treatment with mixed amphetamine salts demonstrated a statistically significant increase in the resting heart rate [+5.7 bpm (3.6, 7.8), p < 0.0001] and systolic blood pressure [+2.0 mmHg (0.8, 3.2), p = 0.005] compared to subjects randomised to placebo [1 ]. A significant increased risk in resting heart rate >90 bpm [4.2% (n = 50) versus 1.7% (n = 8), odds ratio (OR) = 2.75 (1.3,6.7), p = 0.006] was found [l ]. A retrospective cohort study of new amphetamine users (n = 38,586) showed that the propensity score-adjusted hazard ratio for sudden death/ventricular arrhythmia was 1.18 (95% confidence interval [Cl] 0.55-2.54), for stroke 0.80 (95% Cl 0.44-1.47), for myocardial infarction 0.75 (95% Cl 0.42-1.35), and 0.78 for stroke/myocardial infarction (95% CEO.51-1.19) [2 ]. In a review of claims of privately insured young people, ages 6-21 years, without known cardiovascular risk factors (n = 171,126) that included all methylphenidate and... 

Controlled Studies A controlled, randomised study compared oral risperidone, sodium divalproex in children and adolescents with bipolar I mania or mixed phase [23/d. Increased weight and BMI were significantly greater with risperidone treatment than with lithium or sodium divalproex treatment. There was a significant increase in LDL-cholesterol and decrease in HDL-cholesterol for the risperidone and sodium divalproex groups QTc prolongation (>440 ms) was reported in 9.0% of risperidone (also greatest increases), 10.0% of lithium and 3.0% of sodium divalproex-treated patients. 

---